Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
27,342,861
-
Share change
-
-364,208
-
Total reported value
-
$4,929,918,722
-
Put/Call ratio
-
33%
-
Price per share
-
$180.30
-
Number of holders
-
298
-
Value change
-
-$51,223,785
-
Number of buys
-
149
-
Number of sells
-
139
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q1 2025
As of 31 Mar 2025,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
298 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,342,861 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Capital World Investors, Redmile Group, LLC, Frazier Life Sciences Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, and UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC.
This page lists
298
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.